New imaging study aims to unmask why some prostate cancer metastases resist treatment
NCT ID NCT07302763
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will use special PET scans with two different tracers to see how each individual prostate cancer metastasis responds to therapy. Researchers want to understand why some metastases shrink while others grow during the same treatment. The goal is to better characterize resistance patterns and guide future treatment decisions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
PET tracers (FDG and PSMA)
What this could lead to
If successful, this could help doctors identify which metastases are resistant to therapy, potentially guiding more personalized treatment decisions.
What could go wrong
This is an early-stage imaging study with only 45 participants, so results may not apply to all patients. It does not test a new treatment, only how to better monitor existing ones.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MCRPC (METASTATIC CASTRATION-RESISTANT PROSTATE CANCER) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Québec-Université Laval
RECRUITINGQuébec, Quebec, G1J1Z4, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••